CARIBOU BIOSCIENCES INC (CRBU) Stock Income Statement
NASDAQ:CRBU - Nasdaq - US1420381089 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.92M | 9.99M | 34.48M | 13.85M | 9.60M | |||
| Operating Expenses | 173.44M | 176.61M | 150.54M | 120.25M | 76.57M | |||
| Research and Development | 131.90M | 130.15M | 112.08M | 82.23M | 52.26M | |||
| Selling, General, and Administrative Expenses | 41.55M | 46.46M | 38.46M | 38.02M | 24.32M | |||
| Operating Income | -163.53M | -166.62M | -116.06M | -106.40M | -66.98M | |||
| Interest Income/Expense | N/A | N/A | -6.00K | -130.00K | 140.00K | |||
| Other Income/Expense | 15.77M | 17.50M | 14.19M | 7.18M | -1.35M | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 1.58M | |||
| Income Before Taxes | -147.87M | -149.11M | -101.88M | -99.35M | -66.60M | |||
| Income Tax | N/A | -9.00K | 193.00K | 70.00K | 320.00K | |||
| Net Income | -147.86M | -149.10M | -102.07M | -99.42M | -66.92M | |||
| EBITDA | -159.15M | -162.69M | -112.53M | -104.78M | -66.00M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.62 | -1.65 | -1.38 | -1.64 | -1.11 | |||
| Non GAAP EPS | -1.62 | -1.65 | -1.45 | -1.64 | N/A | |||
| Statistics | ||||||||
| Profit Margin | -1490.84% | -1491.95% | -296.05% | -717.83% | -697.08% | |||
| Operating Profit Margin | -1648.79% | -1667.16% | -336.63% | -768.23% | -697.71% | |||
All data in USD